Trials / Active Not Recruiting
Active Not RecruitingNCT05639088
Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes
Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes: A Randomized Controlled Trial of SHIFT2
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also include a caregiver. Results from this study will inform clinical recommendations regarding self-management best practices for AYAs with T1D prior to transitioning to adult medical care.
Detailed description
Investigators will recruit adolescents and young adults ages 16-22 years with T1D and a parent/guardian. Families will participate in one of two 6-month treatments: 1) SHIFT2, engaging in monthly sessions with transition coaches providing education on diabetes management and healthcare transition, or 2) Enhanced treatment (TAU+), engaging in routine medical care and receiving monthly education (no coaches).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Transition preparation program | AYA will participate in virtual or in-person sessions with a transition coach and receive bi-weekly messages that encourage self-management. Caregivers will attend a virtual or in-person session with a transition coach. |
| OTHER | Educational materials | AYA and caregivers will receive educational materials regarding healthcare transition and diabetes management monthly for 6 months |
Timeline
- Start date
- 2023-08-24
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
- First posted
- 2022-12-06
- Last updated
- 2026-04-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05639088. Inclusion in this directory is not an endorsement.